These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 17054057)
1. [New agents for solid tumours]. Raida M Dtsch Med Wochenschr; 2006 Oct; 131(43):2407-10. PubMed ID: 17054057 [No Abstract] [Full Text] [Related]
2. [Tyrosine kinase inhibitors in tumor therapy--part 1. Molecular and genetic fundamentals]. Grimm CF; Blum HE; Geissler M Dtsch Med Wochenschr; 2005 May; 130(21):1318-22. PubMed ID: 15902620 [No Abstract] [Full Text] [Related]
3. Tyrosine kinases as targets for cancer therapy. Krause DS; Van Etten RA N Engl J Med; 2005 Jul; 353(2):172-87. PubMed ID: 16014887 [No Abstract] [Full Text] [Related]
4. [Limitations in application of imatinib in hematologic malignancies: are there new principal solutions?]. Rukavitsyn OA; Pop VP Ter Arkh; 2008; 80(7):80-4. PubMed ID: 18763606 [No Abstract] [Full Text] [Related]
5. Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinases. Chase A; Cross NC Clin Sci (Lond); 2006 Oct; 111(4):233-49. PubMed ID: 16961463 [TBL] [Abstract][Full Text] [Related]
9. Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases. Heinrich MC; Joensuu H; Demetri GD; Corless CL; Apperley J; Fletcher JA; Soulieres D; Dirnhofer S; Harlow A; Town A; McKinley A; Supple SG; Seymour J; Di Scala L; van Oosterom A; Herrmann R; Nikolova Z; McArthur AG; Clin Cancer Res; 2008 May; 14(9):2717-25. PubMed ID: 18451237 [TBL] [Abstract][Full Text] [Related]
10. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer. Albo D; Farrow B; Berger DH Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357 [TBL] [Abstract][Full Text] [Related]
11. Antibodies and hematologic malignancies. Smith MR Cancer J; 2008; 14(3):184-90. PubMed ID: 18536558 [TBL] [Abstract][Full Text] [Related]
12. Angiogenesis inhibitors in the treatment of lung cancer. Sun S; Schiller JH Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557 [TBL] [Abstract][Full Text] [Related]
18. [Signal transduction by protein tyrosine kinases and antitumor agents]. Mao YJ; Li HH; Li JF; Shen JS Yao Xue Xue Bao; 2008 Apr; 43(4):323-34. PubMed ID: 18664191 [TBL] [Abstract][Full Text] [Related]
19. [Recent topics on leukemia: New molecular targeting therapy]. Hirai H Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1036-42. PubMed ID: 12866451 [No Abstract] [Full Text] [Related]
20. [New therapeutic approaches in glioblastomas]. Le Guilloux J; Carpentier AF Rev Neurol (Paris); 2008; 164(6-7):554-9. PubMed ID: 18565354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]